1-1 of 1
Keywords: Second-line chemotherapy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Outcome of Paclitaxel and Carboplatin as Second-Line Chemotherapy for Advanced Urothelial Carcinoma Resistant to First-Line Therapy with Gemcitabine and Cisplatin

Available to Purchase
Subject Area:
Further Areas
Tomoaki Terakawa, Hideaki Miyake, Naoki Yokoyama, Akira Miyazaki, Hiroyuki Tanaka, Takaaki Inoue, Masato Fujisawa
Journal: Urologia Internationalis
Urol Int (2014) 92 (2): 180–185.
https://doi.org/10.1159/000354149
Published Online: 13 November 2013
... received second-line chemotherapy consisting of paclitaxel (175 mg/m 2 ) and carboplatin (area under the curve 5). TC therapy was repeated every 3 weeks and was continued until disease progression or intolerable toxicity was observed. Results: The baseline patient characteristics were rather favorable...
View article titled, Clinical Outcome of Paclitaxel and Carboplatin as Second-Line Chemotherapy for Advanced Urothelial Carcinoma Resistant to First-Line Therapy with Gemcitabine and Cisplatin
Open the PDF for Clinical Outcome of Paclitaxel and Carboplatin as Second-Line Chemotherapy for Advanced Urothelial Carcinoma Resistant to First-Line Therapy with Gemcitabine and Cisplatin in another window